However, a discussion was presented by Sundkvist et al., who achieved these results through their own observations on a group of 60 patients with CRC from a similar human population (Scandinavian population) which did not confirm an association between reduced ghrelin levels and increased CRC risk in the years before diagnosis. The gene discussed is GHRL; the disease is colorectal carcinoma.